{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:22:57Z","timestamp":1790752977144,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.beem.2020.101386","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T03:47:05Z","timestamp":1580788025000},"page":"101386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Adrenocortical hyperplasia: A multifaceted disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Isabelle","family":"Bourdeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9fanie","family":"Parisien-La Salle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9996","key":"10.1016\/j.beem.2020.101386_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.beem.2020.101386_bib2","first-page":"e204","article-title":"Adrenal nodules in patients with Cushing's disease: prevalence, clinical significance and follow-up","volume":"34","author":"Albiger","year":"2011","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.beem.2020.101386_bib3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0022-3476(99)70302-1","article-title":"Cushing's syndrome caused by nodular adrenal hyperplasia in children with mccune-albright syndrome","volume":"134","author":"Kirk","year":"1999","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.beem.2020.101386_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.0.1310067","article-title":"Acth-independent massive bilateral adrenal disease (aimbad): a subtype of Cushing's syndrome with major diagnostic and therapeutic implications","volume":"131","author":"Lieberman","year":"1994","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2020.101386_bib5","doi-asserted-by":"crossref","first-page":"E926","DOI":"10.1210\/jc.2014-4204","article-title":"Armc5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences","volume":"100","author":"Espiard","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2020.101386_bib6","first-page":"75","article-title":"Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome","volume":"22","author":"Lacroix","year":"2001","journal-title":"Endocr Rev"},{"issue":"10","key":"10.1016\/j.beem.2020.101386_bib7","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.4158\/EP15756.OR","article-title":"Germline deletion of Armc5 in familial primary macronodular adrenal hyperplasia","volume":"21","author":"Suzuki","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2020.101386_bib8","doi-asserted-by":"crossref","first-page":"105316","DOI":"10.1016\/j.jsbmb.2019.02.011","article-title":"High expression of adrenal P450 aromatase (Cyp19a1) in association with armc5-primary bilateral macronodular adrenocortical hyperplasia","volume":"191","author":"Berthon","year":"2019","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"2","key":"10.1016\/j.beem.2020.101386_bib9","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.1210\/jc.2010-1222","article-title":"Clinical, biochemical, and molecular characterization of macronodular adrenocortical hyperplasia of the zona reticularis: a new syndrome","volume":"96","author":"Ghayee","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2020.101386_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/EJE-10-0195","article-title":"Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome","volume":"163","author":"Libe","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2020.101386_bib11","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1210\/jc.2009-0516","article-title":"Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors","volume":"94","author":"Hsiao","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2020.101386_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2265.2005.02411.x","article-title":"Expression of acth receptor pathway genes in glucose-dependent insulinotrophic peptide (Gip)-Dependent Cushing's syndrome","volume":"64","author":"Antonini","year":"2006","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2020.101386_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2009.03689.x","article-title":"Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction","volume":"73","author":"Lacroix","year":"2010","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2020.101386_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MED.0b013e32832b7043","article-title":"Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment","volume":"16","author":"Mazzuco","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"10.1016\/j.beem.2020.101386_bib15","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1530\/EJE-18-0296","article-title":"Management of endocrine disease: differential diagnosis, investigation and therapy of bilateral adrenal incidentalomas","volume":"179","author":"Bourdeau","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2020.101386_bib16","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1210\/jc.2011-1397","article-title":"(18)F-Fdg-Pet\/Ct imaging of acth-independent macronodular adrenocortical hyperplasia (aimah) demonstrating increased (18)F-Fdg uptake","volume":"96","author":"Alencar","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2020.101386_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1148\/radiology.216.3.r00au40797","article-title":"Adrenocorticotropin-independent macronodular adrenal hyperplasia: an uncommon cause of primary adrenal hypercortisolism","volume":"216","author":"Doppman","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.beem.2020.101386_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2017.06.027","article-title":"The role of Armc5 in human cell cultures from nodules of primary macronodular adrenocortical hyperplasia (pmah)","volume":"460","author":"Cavalcante","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2020.101386_bib19","first-page":"215","article-title":"Acth-independent macronodular adrenocortical hyperplasia: immunohistochemical and in situ hybridization studies of steroidogenic enzymes","volume":"7","author":"Sasano","year":"1994","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.beem.2020.101386_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2012.04403.x","article-title":"Genetic aspects of adrenocortical tumours and hyperplasias","volume":"77","author":"Mazzuco","year":"2012","journal-title":"Clin Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2020.101386_bib21","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (Men1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2020.101386_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-11-0679","article-title":"Adrenal involvement in Men1. Analysis of 715 cases from the groupe D'etude des tumeurs endocrines database","volume":"166","author":"Gatta-Cherifi","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2020.101386_bib23","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.4158\/EP10213.CR","article-title":"Corticotropin-independent macronodular adrenal hyperplasia associated with insulinoma","volume":"17","author":"Lee","year":"2011","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.beem.2020.101386_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1507\/endocrj.53.111","article-title":"A\u00a0case of adrenocorticotropin-independent bilateral adrenal macronodular hyperplasia (aimah) with primary hyperparathyroidism (phpt)","volume":"53","author":"Sato","year":"2006","journal-title":"Endocr J"},{"issue":"7\u20138 Pt 2","key":"10.1016\/j.beem.2020.101386_bib25","first-page":"e139","article-title":"Genetics of primary macronodular adrenal hyperplasia","volume":"47","author":"Fragoso","year":"2018","journal-title":"Presse Med"},{"issue":"6","key":"10.1016\/j.beem.2020.101386_bib26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/DCR.0000000000001008","article-title":"Characteristics of adrenal masses in familial adenomatous polyposis","volume":"61","author":"Shiroky","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"10.1016\/j.beem.2020.101386_bib27","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/jc.2004-2377","article-title":"Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigation","volume":"90","author":"Matyakhina","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2020.101386_bib28","first-page":"430","article-title":"Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer","volume":"189","author":"Shuch","year":"2013","journal-title":"J\u00a0Urol"},{"issue":"22","key":"10.1016\/j.beem.2020.101386_bib29","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"Armc5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome","volume":"369","author":"Assie","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2020.101386_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.coemr.2019.07.010","article-title":"Molecular mechanisms of Armc5 mutations in adrenal pathophysiology","volume":"8","author":"Stratakis","year":"2019","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"8","key":"10.1016\/j.beem.2020.101386_bib31","doi-asserted-by":"crossref","first-page":"E1501","DOI":"10.1210\/jc.2013-4237","article-title":"Armc5 mutations are a frequent cause of primary macronodular adrenal hyperplasia","volume":"99","author":"Alencar","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2020.101386_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2265.2005.02387.x","article-title":"Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial acth-independent macronodular adrenal hyperplasia","volume":"63","author":"Lee","year":"2005","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2020.101386_bib33","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2014-2648","article-title":"Molecular and clinical evidence for an Armc5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma","volume":"100","author":"Elbelt","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2020.101386_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/EJE-15-0642","article-title":"Armc5 mutations in a large French-Canadian family with cortisol-secreting beta-adrenergic\/vasopressin responsive bilateral macronodular adrenal hyperplasia","volume":"174","author":"Bourdeau","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2020.101386_bib35","doi-asserted-by":"crossref","first-page":"E1784","DOI":"10.1210\/jc.2014-1265","article-title":"Armc5 mutations are common in familial bilateral macronodular adrenal hyperplasia","volume":"99","author":"Gagliardi","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2020.101386_bib36","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/JOE-14-0568","article-title":"Genetics of primary macronodular adrenal hyperplasia","volume":"224","author":"Fragoso","year":"2015","journal-title":"J\u00a0Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2020.101386_bib37","doi-asserted-by":"crossref","first-page":"E1113","DOI":"10.1210\/jc.2013-4280","article-title":"Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (Armc5) gene: a clinical and genetic investigation","volume":"99","author":"Faucz","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2020.101386_bib38","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s12020-016-0956-z","article-title":"A\u00a0multicenter experience on the prevalence of Armc5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype","volume":"55","author":"Albiger","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2020.101386_bib39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.mce.2016.08.018","article-title":"Analysis of Armc5 expression in human tissues","author":"Berthon","year":"2017","journal-title":"Mol Cell Endocrinol 441"},{"issue":"18","key":"10.1016\/j.beem.2020.101386_bib40","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1093\/hmg\/ddx235","article-title":"Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function","volume":"26","author":"Berthon","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2020.101386_bib41","doi-asserted-by":"crossref","first-page":"13834","DOI":"10.1038\/ncomms13834","article-title":"Armc5 deletion causes developmental defects and compromises T-cell immune responses","volume":"8","author":"Hu","year":"2017","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.beem.2020.101386_bib42","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1210\/jc.2002-021362","article-title":"Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of Gnas1 gene","volume":"88","author":"Fragoso","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2020.101386_bib43","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng1809","article-title":"A\u00a0genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11a4 (Pde11a) in individuals with adrenocortical hyperplasia","volume":"38","author":"Horvath","year":"2006","journal-title":"Nat Genet"},{"issue":"6186","key":"10.1016\/j.beem.2020.101386_bib44","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1126\/science.1249480","article-title":"Activating hotspot L205r mutation in prkaca and adrenal Cushing's syndrome","volume":"344","author":"Cao","year":"2014","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.beem.2020.101386_bib45","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of pka catalytic subunit in adrenal Cushing's syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2020.101386_bib46","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1750-1172-8-142","article-title":"Acth-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in\u00a0vivo and in\u00a0vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11beta-hydroxylase","volume":"8","author":"Hofland","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.beem.2020.101386_bib47","doi-asserted-by":"crossref","first-page":"M45","DOI":"10.1530\/EJE-15-0200","article-title":"Multiple aberrant hormone receptors in Cushing's syndrome","volume":"173","author":"El Ghorayeb","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2020.101386_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.beem.2018.01.003","article-title":"Aberrant G-protein coupled hormone receptor in adrenal diseases","volume":"32","author":"St-Jean","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"10","key":"10.1016\/j.beem.2020.101386_bib49","doi-asserted-by":"crossref","first-page":"E253","DOI":"10.1210\/jc.2009-2281","article-title":"Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome","volume":"95","author":"Assie","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2020.101386_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1530\/eje.1.02324","article-title":"Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors","volume":"156","author":"Vezzosi","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"21","key":"10.1016\/j.beem.2020.101386_bib51","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJM199911183412104","article-title":"Leuprolide acetate therapy in luteinizing hormone--dependent Cushing's syndrome","volume":"341","author":"Lacroix","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.beem.2020.101386_bib52","first-page":"57","article-title":"Functional implications of lh\/hcg receptors in pregnancy-induced cushing syndrome","volume":"1","author":"Plockinger","year":"2017","journal-title":"J\u00a0Endocr Soc"},{"issue":"18","key":"10.1016\/j.beem.2020.101386_bib53","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92184","article-title":"Adrenal gipr expression and chromosome 19q13 microduplications in gip-dependent Cushing's syndrome","volume":"2","author":"Lecoq","year":"2017","journal-title":"JCI Insight"},{"issue":"16","key":"10.1016\/j.beem.2020.101386_bib54","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2169\/internalmedicine.51.7547","article-title":"A\u00a0rare case of adrenocorticotropic hormone (Acth)-Independent macroadrenal hyperplasia showing ectopic production of acth","volume":"51","author":"Iwata","year":"2012","journal-title":"Intern Med"},{"issue":"9","key":"10.1016\/j.beem.2020.101386_bib55","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1590\/S0004-27302007000900007","article-title":"Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing beta-blocker-sensitive Cushing's syndrome","volume":"51","author":"Mazzuco","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"22","key":"10.1016\/j.beem.2020.101386_bib56","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1056\/NEJMoa1215245","article-title":"Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia","volume":"369","author":"Louiset","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.beem.2020.101386_bib57","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/EJE-13-0308","article-title":"Autocrine\/paracrine regulatory mechanisms in adrenocortical neoplasms responsible for primary adrenal hypercorticism","volume":"169","author":"Lefebvre","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2020.101386_bib58","first-page":"5534","article-title":"Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome","volume":"86","author":"Bourdeau","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2020.101386_bib59","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/ERC-15-0541","article-title":"Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism?","volume":"23","author":"Guerin","year":"2016","journal-title":"Endocr Relat Canc"},{"issue":"2","key":"10.1016\/j.beem.2020.101386_bib60","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European society of Endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2020.101386_bib61","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1530\/EJE-15-0566","article-title":"Biochemical and clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism and bilateral adrenal incidentalomas","volume":"173","author":"Perogamvros","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2020.101386_bib62","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/cen.12763","article-title":"An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experience","volume":"82","author":"Albiger","year":"2015","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10.1016\/j.beem.2020.101386_bib63","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00268-013-2059-9","article-title":"The role of unilateral adrenalectomy in corticotropin-independent bilateral adrenocortical hyperplasias","volume":"37","author":"Xu","year":"2013","journal-title":"World J Surg"},{"issue":"12","key":"10.1016\/j.beem.2020.101386_bib64","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1210\/jc.2015-2662","article-title":"Unilateral adrenalectomy as a first-line treatment of Cushing's syndrome in patients with primary bilateral macronodular adrenal hyperplasia","volume":"100","author":"Debillon","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2020.101386_bib65","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1210\/jc.2018-02204","article-title":"Long-term outcome of primary bilateral macronodular adrenocortical hyperplasia after unilateral adrenalectomy","volume":"104","author":"Osswald","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101386_bib66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.urology.2015.11.043","article-title":"The use of three-dimensional printers for partial adrenalectomy: estimating the resection limits","volume":"90","author":"Srougi","year":"2016","journal-title":"Urology"},{"issue":"12","key":"10.1016\/j.beem.2020.101386_bib67","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.1210\/jc.2018-02638","article-title":"Mifepristone treatment in Four cases of primary bilateral macronodular adrenal hyperplasia (bmah)","volume":"104","author":"Cohan","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7\u20138 Pt 2","key":"10.1016\/j.beem.2020.101386_bib68","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.lpm.2018.07.005","article-title":"Genetics of micronodular adrenal hyperplasia and Carney complex","volume":"47","author":"Tirosh","year":"2018","journal-title":"Presse Med"},{"issue":"6\u20137","key":"10.1016\/j.beem.2020.101386_bib69","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-2007-978914","article-title":"Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to cushing syndrome","volume":"30","author":"Stratakis","year":"1998","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.1016\/j.beem.2020.101386_bib70","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00000478-198405000-00002","article-title":"Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the cushing syndrome","volume":"8","author":"Shenoy","year":"1984","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.beem.2020.101386_bib71","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2265.2008.03273.x","article-title":"Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (ppnad)","volume":"69","author":"Tadjine","year":"2008","journal-title":"Clin Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2020.101386_bib72","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","article-title":"Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation","volume":"86","author":"Stratakis","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2020.101386_bib73","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1210\/jc.2003-032247","article-title":"Cyclical cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity?","volume":"89","author":"Gunther","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2020.101386_bib74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s13244-012-0208-6","article-title":"The complex of myxomas, spotty skin pigmentation and endocrine overactivity (Carney complex): imaging findings with clinical and pathological correlation","volume":"4","author":"Courcoutsakis","year":"2013","journal-title":"Insights Imaging"},{"issue":"2\u201303","key":"10.1016\/j.beem.2020.101386_bib75","first-page":"156","article-title":"Carney complex","volume":"127","author":"Kamilaris","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"10.1016\/j.beem.2020.101386_bib76","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2008-2333","article-title":"Mutations in regulatory subunit type 1a of cyclic adenosine 5'-monophosphate-dependent protein kinase (Prkar1a): phenotype Analysis in 353 patients and 80 different genotypes","volume":"94","author":"Bertherat","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2020.101386_bib77","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-131-8-199910190-00006","article-title":"Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease","volume":"131","author":"Stratakis","year":"1999","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.beem.2020.101386_bib78","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12020-017-1436-9","article-title":"Efficacy of dexamethasone suppression test during the diagnosis of primary pigmented nodular adrenocortical disease in Chinese adrenocorticotropic hormone-independent cushing syndrome","volume":"59","author":"Chen","year":"2018","journal-title":"Endocrine"},{"issue":"8","key":"10.1016\/j.beem.2020.101386_bib79","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1210\/jc.2002-022001","article-title":"Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in\u00a0vitro and are associated with increased expression of the glucocorticoid receptor","volume":"88","author":"Bourdeau","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2020.101386_bib80","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1210\/jc.2009-0031","article-title":"The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase a catalytic subunits","volume":"94","author":"Louiset","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2020.101386_bib81","first-page":"494","article-title":"Estradiol stimulates cortisol production by adrenal cells in estrogen-dependent primary adrenocortical nodular dysplasia","volume":"77","author":"Caticha","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"15","key":"10.1016\/j.beem.2020.101386_bib82","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87958","article-title":"Pka regulatory subunit 1a inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal disease","volume":"1","author":"Bram","year":"2016","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.beem.2020.101386_bib83","first-page":"3607","article-title":"Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex)","volume":"81","author":"Stratakis","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"23","key":"10.1016\/j.beem.2020.101386_bib84","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/01.CIR.98.23.2560","article-title":"Identification of a novel genetic locus for familial cardiac myxomas and Carney complex","volume":"98","author":"Casey","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.beem.2020.101386_bib85","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase a type I-alpha regulatory subunit in patients with the Carney complex","volume":"26","author":"Kirschner","year":"2000","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.beem.2020.101386_bib86","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1210\/jc.2002-020592","article-title":"Mutations of the Prkar1a gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease","volume":"87","author":"Groussin","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2020.101386_bib87","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/344579","volume":"71","author":"Groussin","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"7","key":"10.1016\/j.beem.2020.101386_bib88","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJMc0706182","article-title":"Mutation in Pde8b, a cyclic amp-specific phosphodiesterase in adrenal hyperplasia","volume":"358","author":"Horvath","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.beem.2020.101386_bib89","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2265.2012.04366.x","article-title":"Identification of novel genetic variants in phosphodiesterase 8b (Pde8b), a camp-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours","volume":"77","author":"Rothenbuhler","year":"2012","journal-title":"Clin Endocrinol"},{"issue":"10","key":"10.1016\/j.beem.2020.101386_bib90","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1210\/jc.2008-0631","article-title":"Wnt\/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate\/protein kinase a signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors","volume":"93","author":"Gaujoux","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2020.101386_bib91","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/sj.onc.1207277","article-title":"Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators","volume":"23","author":"Bourdeau","year":"2004","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.beem.2020.101386_bib92","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2011-2244","article-title":"A\u00a0large family with Carney complex caused by the S147g Prkar1a mutation shows a unique spectrum of disease including adrenocortical cancer","volume":"97","author":"Anselmo","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2020.101386_bib93","doi-asserted-by":"crossref","first-page":"E202","DOI":"10.1210\/jc.2011-2321","article-title":"Carney complex with adrenal cortical carcinoma","volume":"97","author":"Morin","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2020.101386_bib94","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PAS.0000000000000748","article-title":"Cushing syndrome in Carney complex: clinical, pathologic, and molecular genetic findings in the 17 affected mayo clinic patients","volume":"41","author":"Lowe","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.beem.2020.101386_bib95","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1172\/JCI115046","article-title":"Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance","volume":"87","author":"Hurley","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2020.101386_bib96","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000342505","article-title":"Primary generalized familial and sporadic glucocorticoid resistance (chrousos syndrome) and hypersensitivity","volume":"24","author":"Charmandari","year":"2013","journal-title":"Endocr Dev"},{"issue":"2","key":"10.1016\/j.beem.2020.101386_bib97","doi-asserted-by":"crossref","first-page":"124","DOI":"10.14310\/horm.2002.1728","article-title":"Novel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromes","volume":"16","author":"Nicolaides","year":"2017","journal-title":"Hormones (Basel)"},{"issue":"10","key":"10.1016\/j.beem.2020.101386_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013563","article-title":"Familial glucocorticoid receptor haploinsufficiency by non-sense mediated mrna decay, adrenal hyperplasia and apparent mineralocorticoid excess","volume":"5","author":"Bouligand","year":"2010","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.beem.2020.101386_bib99","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1530\/EJE-17-1071","article-title":"Significant prevalence of Nr3c1 mutations in incidentally discovered bilateral adrenal hyperplasia: results of the French muta-gr study","volume":"178","author":"Vitellius","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.beem.2020.101386_bib100","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1136\/archdischild-2017-313873","article-title":"Update on adrenal steroid hormone biosynthesis and clinical implications","volume":"104","author":"Bacila","year":"2019","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.beem.2020.101386_bib101","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4158\/EP151085.RA","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency presenting as adrenal incidentaloma: a systematic review and meta-analysis","volume":"22","author":"Falhammar","year":"2016","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.beem.2020.101386_bib102","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/JOE-19-0193","article-title":"Molecular mechanisms in primary aldosteronism","volume":"242","author":"De Sousa","year":"2019","journal-title":"J\u00a0Mol Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2020.101386_bib103","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1210\/jc.2009-2010","article-title":"Adrenocortical zonation in humans under normal and pathological conditions","volume":"95","author":"Nishimoto","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2020.101386_bib104","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41588-018-0053-8","article-title":"A\u00a0gain-of-function mutation in the Clcn2 chloride channel gene causes primary aldosteronism","volume":"50","author":"Fernandes-Rosa","year":"2018","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.beem.2020.101386_bib105","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A\u00a0novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism","volume":"93","author":"Geller","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6018","key":"10.1016\/j.beem.2020.101386_bib106","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.beem.2020.101386_bib107","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel Cacna1h causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"Elife"},{"issue":"9","key":"10.1016\/j.beem.2020.101386_bib108","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline Cacna1d calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.beem.2020.101386_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191602","article-title":"Armc5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia","volume":"13","author":"Yu","year":"2018","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.beem.2020.101386_bib110","doi-asserted-by":"crossref","first-page":"E900","DOI":"10.1210\/jc.2014-4167","article-title":"Primary aldosteronism and Armc5 variants","volume":"100","author":"Zilbermint","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101386_bib111","article-title":"Armc5 mutation in a Portuguese family with primary bilateral macronodular adrenal hyperplasia (pbmah)","volume":"2017","author":"Rego","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"3","key":"10.1016\/j.beem.2020.101386_bib112","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1507\/endocrj.EJ17-0317","article-title":"Whole-genome sequencing revealed armadillo repeat containing 5 (Armc5) mutation in a Chinese family with acth-independent macronodular adrenal hyperplasia","volume":"65","author":"Zhang","year":"2018","journal-title":"Endocr J"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X20300130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X20300130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:55:30Z","timestamp":1761497730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X20300130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":112,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1521690X20300130"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2020.101386","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adrenocortical hyperplasia: A multifaceted disease","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2020.101386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101386"}}